← All companies

Amylyx

Healthcare & Life Sci

Company overview

Amylyx is a biopharmaceutical company that develops experimental therapies aimed mainly at treating neurodegenerative diseases. Its main product, AMX0035, is a combination of taurursodiol and sodium phenylbutyrate designed to protect nerve cells. The company was established in 2013 by Joshua Cohen and Justin Klee.

Amylyx is headquartered in Cambridge, Massachusetts.

Industry
Healthcare & Life Sci
Headquarters
Cambridge, United States

Filters

Create your account

Create an account to save jobs and track applications.